Corporate Engagement

Our Corporate Engagement program promotes corporate responsibility regarding all aspects of reproductive and maternal health.

Rhia Ventures works with investors in publicly traded stocks who are committed to leveraging their investment portfolios to effect positive social outcomes. Together, we engage directly with companies in dialogue; attend shareholder meetings; file shareholder proposals; and provide thought leadership through our research, reports, and other publications.

In 2020, Rhia Ventures released Hidden Value: The Business Case for Reproductive Health, a groundbreaking report that connects how access to comprehensive reproductive health care impacts a company’s bottom line and the corporate workforce. Prepared in partnership with the consultancy FSG, the report identifies five major factors that argue for making access to reproductive health care a business imperative.

The COVID-19 pandemic is undermining access to time-sensitive and essential reproductive healthcare needs. Read here what companies can do to ensure that their employees get the reproductive healthcare they need during this crisis.




investor and corporate audiences on the economy-wide and firm-level benefits of improving access to affordable reproductive and maternal health care.

Give visibility and voice

to investors who support choice, contraception and maternal and reproductive health.


for companies to provide first-rate reproductive health insurance coverage that covers all forms of contraception as well as elective abortion; generous parental and family leave policies; fertility benefits; support for child care; and protection against pregnancy discrimination.


companies to support public policies that uphold these rights, values, and priorities.


companies to ensure that their political spending and lobbying activities do not undermine these values and priorities.

For more information, contact
Shelley Alpern, Director of Shareholder Advocacy, at